Navigation Links
Monsanto Attempts to Lockout Socially Responsible Shareholder at Annual Meeting
Date:1/20/2012

ST. LOUIS, Jan. 20, 2012 /PRNewswire-USNewswire/ -- On Tuesday, January 24 at 1:30 PM, Monsanto officers and shareholders will vote on a shareholder proposal to create a study of "material financial risks or operational impacts" associated with its chemical products and genetically modified organisms (GMOs).

The proposal represents one of the strongest signals to date that the biotech food conglomerate is facing growing consumer, legal, and regulatory uncertainties. As of today, however Monsanto has told John Harrington that they will not recognize his proxy who would speak on behalf of the resolution for only three minutes under normal circumstances.

The meeting itself is only open to shareholders but concerned citizens will be demonstrating outside the northeast entrance to Monsanto's Lindberg campus beginning at 12:00 noon. Monsanto Headquarters is located at 800 North Lindberg Boulevard in St. Louis, MO.

Adam Eidinger, an organic food activist who recently led a walk from NY to Washington DC on behalf of honest food labeling, will present the shareholder resolution on behalf of Napa, California based Harrington Investments (HII) with help from the Pesticide Action Network of North America (PANNA).

Eidinger will be available for interview before and after the shareholder meeting, which he will drive a "Label GMO" art car to attend. Representatives from HII and PANNA will be also available for interview before and after the shareholder meeting. Eidinger's written testimony is available by request.

In its statement recommending shareholders to vote against the HII resolution, Monsanto management stated that, "Farmers should have the freedom to choose which production method is best suited for their needs, whether organic, non-GM conventional or biotechnology traits. All of these systems can and do work effectively side by side…"

John Harrington, CEO of Harrington Investments questions the veracity of Monsanto's statement: "While I am heartened by Monsanto's sudden concern for the freedom of farmers, the unfortunate reality facing American farmers right now, is that genetic drift from GMO crops is contaminating their conventional and organic crops. This can be disastrous because many GMO crops cannot be sold to important markets, such as Europe, China and Japan. The potential legal implications for Monsanto are staggering."

Eidinger, who organized last October's a 100 person, 313 mile "Right2Know March" from New York City to the White House for federally mandated GMO food labeling says: "With the rise or Round-Up resistant 'superweeds' the company is simply telling farmers to spray even more toxic herbicides including 2,4 D, the main ingredient in Agent Orange. Many people are struggling to avoid GMOs and chemicals used on them in the food they eat due to serious health and environmental concerns yet Americans have no right to know what we are eating largely due to the close ties Monsanto has to President Obama's USDA and FDA which has ignored more than 500,000 Americans who have signed on to the JustLabelIt.org petition to the FDA."

More information about the protest may be found at http://www.facebook.com/events/340545799304131/

 

 


'/>"/>
SOURCE Harrington Investments
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Monsanto Declared Worst Company of 2011 by NaturalSociety
2. Monsantos Kerry Preete to Address Investors at Goldman Sachs Agricultural Biotech Forum
3. Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors
4. Monsanto Reconfirms 2010 Guidance and 2012 Financial Commitments on Strength of Larger Expected Launches for Blockbuster Products
5. Monsanto Opens First Biotechnology Research Center in China
6. Monsanto and Huazhong Agricultural University Enter Into Collaboration Focusing on Development of Plant Biotechnology
7. Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology
8. Monsanto Is on the Verge of a Technology Explosion, Executives Tell Investors at Annual Field Event
9. Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres
10. Monsanto, BASF Scientists Disclose Discovery of Gene Conferring Drought Tolerance in Corn Plants
11. Monsantos Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
Breaking Biology Technology:
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
Breaking Biology News(10 mins):